BASF is to strengthen its standing within the nutrition industry by creating one global business unit, Nutrition Ingredients that focuses on products such as vitamins and carotenoids.
June 2021 and with much of Europe still in the recovery phase post-pandemic, many have an eye on fresh pastures and new challenges. NutraIngredients rounds up those who have taken the plunge in May.
Health ingredient giants BASF Human Nutrition and Gelita announce the formation of two separate distribution agreements with Azelis that capitalises on the group’s European nutraceutical network.
BASF Nutrition & Health are teaming up with Ideogen to introduce an omega-3 fatty acid solution to Europe that addresses the chronic condition Non-Alcoholic Fatty Liver Disease (NAFLD).
As the “one-size-fits-all” nutritional model becomes less relevant, consumer interest in personalized nutrition and ‘taking back control’ is growing, but the past 15 years are littered with harsh lessons. So, why are today’s companies better positioned...
Ingredients giant BASF will collaborate with Irish start-up Nuritas on the discovery and commercialisation of novel functional peptides using DNA analysis and artificial intelligence (AI).
The search for the final missing person following the explosion at BASF’s plant this week has come to an end after divers found a body in the nearby harbour.
Two workers have been killed, one person is still missing and eight have been seriously injured in the explosion at a BASF plant in Ludwigshafen, Germany yesterday.
The omega-3s market is moving toward ever higher concentrations, and BASF is convinced there is ample supply to bear the increased demand on raw material.
By analysing the long-lasting commitments and acquisition activity of major companies Dr Matthew Jones at CPL Business Consultants uses the Red Queen theory to develop an understanding of their corporate mind-set and appetite for acquisitions and partnerships...
Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.
BASF is moving en masse into omega-3 - especially if its bid for Norwegian player Pronova is approved - but it is technology gained from its May acquisition of a high-dose omega-3 start-up on a remote Scottish island, that is exciting the German giant.
Interview: Samy Jandali, VP Nutrition & Health, North America, BASF
Chat to any major ingredients supplier at a trade show and you can expect to hear liberal use of buzzwords from ‘partnership’ and ‘collaboration’ to ‘open innovation’ says Samy Jandali.
One year on from the $3.1 billion acquisition of Cognis, Samy Jandali, VP of nutrition and health North America for BASF, told Stephen Daniells why he is impressed with the progress of the integration and why we can expect more M&A in the nutrition...
BASF is confident it can bring a canola oil to market with sufficient levels of the coveted long-chain omega-3 fatty acids EPA and DHA to make heart health claims by the end of the decade.
Improved logistics and optimised process control technology resulting from a multi million euro investment in its Danish microencapsulation facility will allow greater flexibility in terms of carotenoid and vitamin powder delivery to manufacturers, claims...
Ingredients giant BASF Nutrition has launched a program to band some of its primary human nutrition ingredients together in a move it says will simplify the supply chain for its global customers.
Giant German supplier BASF has increased the price of propionic
acid for the second time since May as energy and raw materials
costs continue to spiral.
The divestiture of a joint venture between BASF and Fortitech will
have no impact on customers, said Fortitech, which confirmed that
it will continue to make its nutrient premixes with the same
ingredients.
BASF has announced that it will be ceasing production of lysine at
its plant in Gunsan, South Korea, marking the end of its amino acid
activity in the face of shrinking margins.
BASF's fine chemicals division has posted strong overall sales for
full year 2006, but weak sales of the amino acid lysine and
carotenoids continued to detract from its performance.
BASF's fine chemicals division has reported a modest increase in
sales for Q3, but EBIT was impacted by the implementation of
measures aimed at reducing costs in the longer term.
Germany chemicals group BASF is implementing a new measure to
combat price pressure on its vitamin businesses in the long-term,
by combining its human and animal nutrition resources under the
banner of a new nutrition unit within...
BASF has announced that it is increasing worldwide prices for
vitamin B2 for animal feed due to increased production and
marketing costs - and an increase for the food grade is likely to
follow.
BASF's fine chemicals division reported a huge rise in operating
profits in second quarter 2006 - no thanks to vitamins. Rather,
credit is given to a swift trade in aroma chemicals and gains from
contract manufacturing and personal...
BASF's acquisition of CropDesign, a Belgian biotech company, will
help establish the German chemical giant as a leader in the
development of important crop traits in corn, soy bean and rape
seed.
BASF's fine chemicals division is bolstered by higher sales volume
of aroma chemicals and vitamins A and E for animal nutrition, but
the pressure over vitamin C and lysine has not abated, dragging
down the division's profitability.
BASF and Daiichi, two of the companies involved in the 1990s
vitamin cartel, have had their fines significantly reduced by a
European court, which ruled that the Commission made errors when
calculating the fines.
German chemical giant BASF is to shed about 3,600 jobs at its main
Ludwigshafen plant over the next three years as part of efforts
ensure the site's competitiveness.
Japanese pharmaceutical firm Takeda will sell off its stakes in
five non-core joint ventures, including the vitamins business that
it operates with Germany's BASF, according to reports.
The German chemicals giant BASF has announced a successful second
quarter, though the company's nutrition and agricultural products
division turned in a poor performance with minimal sales growth and
reduced earnings from the...
The world's number two vitamin maker BASF officially opened its new
vitamin B2 plant in Korea today, increasing its production capacity
for the food and feed grade vitamin and reinforcing its position in
the consolidating vitamins...
The world's number two vitamin maker BASF boosted second quarter
earnings in its agricultural and nutrition segment, despite flat
sales from across the group's businesses and a pessimistic outlook
for the full year.
The latest phase of BASF and Fortitech's human nutrition joint
venture has been completed with the transfer of BASF's Malaysian
production facility to Fortitech's new Fortitech Asia Pacific unit.
Leading German chemical company BASF said today its third quarter
earnings will be impacted by a €100 million charge resulting from
the final settlements with purchasers of its vitamin products in
the US.
German chemicals group BASF said this week that while on schedule
with its expansion of vitamin E production, first announced in
2001, it was anticipating supply bottlenecks at its Ludwigshafen
plant between now and April next year.
BASF, the German chemicals group, has formed a joint venture with
US-based Fortitech focusing on the manufacture, marketing and sales
of human nutrition premix products.
German chemicals group BASF said it performed well last year and is
confident of further growth in 2002 despite difficult trading
conditions. All of the company's divisions performed well, despite
high raw material prices and...
